Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately after Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer

  1. Pujol, J.-L.
  2. Paz-Ares, L.
  3. De Marinis, F.
  4. Dediu, M.
  5. Thomas, M.
  6. Bidoli, P.
  7. Corral, J.
  8. San Antonio, B.
  9. Chouaki, N.
  10. John, W.
  11. Zimmermann, A.
  12. Visseren-Grul, C.
  13. Gridelli, C.
Revue:
Clinical Lung Cancer

ISSN: 1938-0690,  1525-7304

Année de publication: 2014

Volumen: 15

Número: 6

Pages: 418-425

Type: Article

DOI: 10.1016/J.CLLC.2014.06.007 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus